
Sleep Disorders
Latest News

Seltorexant vs Quetiapine: Metabolic Profiles of Participants With MDD and Insomnia Symptoms in Phase 3 Trial

FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
Latest Videos

Podcasts
CME Content
More News

Alixorexton shows promising results in improving wakefulness and reducing daytime sleepiness in patients with narcolepsy type 2.

Explore the complexities of insomnia in older adults, its impact on health, and effective management strategies for improved sleep quality.

Discover the most effective components of cognitive behavioral therapy for chronic insomnia, enhancing treatment outcomes and patient care strategies.

Sleep disruption undermines team coordination in sports, revealing its critical role in collective performance and strategic success.

A new study reveals tasimelteon (Hetlioz) significantly improves sleep onset in chronic insomnia patients.

New phase 3 data reveals seltorexant's potential as a safer adjunctive treatment for major depressive disorder with insomnia, despite not meeting its primary end point.

Cognitive behavioral therapy for insomnia effectively treats chronic insomnia, promoting long-term sleep improvement through targeted behavioral strategies.

Takeda's oveporexton shows promising results in treating narcolepsy type 1, significantly improving symptoms and quality of life in clinical trials.

Alixorexton shows promise as a treatment for narcolepsy type 1, and is the first orexin 2 receptor agonist to demonstrate clinically meaningful and statistically significant impact on wakefulness, cognition, and fatigue with once-daily dosing across a range of doses.

Explore effective strategies for managing narcolepsy, including personalized treatment plans, medication options, and lifestyle interventions for improved patient outcomes.

Discover the complexities of sleep-related eating disorder, its symptoms, triggers, and effective treatments for better sleep health.

Apnimed reveals promising results for AD109, a groundbreaking oral treatment for obstructive sleep apnea.

Positive phase 2 results show that treatment with alixorexton led to statistically significant and dose-dependent improvements in sleep latency among patients with narcolepsy type 1.

What is a sleep disorder? Explore the complexities of their definitions and the impact of circadian rhythms on health and well-being.

Explore the intricate relationship between sleep disorders and psychiatric conditions, diagnostic challenges, and effective management strategies, in this Special Report article.

Explore the complex relationship between insomnia and mental health, and learn more about effective treatments like CBT-I for better sleep and well-being.

There is a critical link between sleep disorders and psychiatric conditions. In this Special Report, examine effective diagnosis and treatment strategies for better patient outcomes.

Effective diagnosis and treatment of comorbid disorders in patients with bipolar enhance care and lead to more optimal mental health outcomes.

Discover the unique approaches to treating sleep disorders in children vs adults, highlighting effective behavioral strategies.

Patients with treatment resistant late-life depression are more likely to respond to antidepressants when sleep is sufficient or has improved.

Do you want to be featured in a future Special Report? Check out our April theme!

In the phase 3 ENCORE trial, AXS-12 reduced the frequency of cataplexy attacks as compared with placebo at week 3 of the double-blind period.

Brain injury was recently recognized as a chronic health condition.

A new collaboration to address sleep disturbances associated with cognitive impairment, an unmet need.

Will this help my sleep and mood? Researchers investigated the effects of noninvasive neurostimulation on sleep quality and depressive symptoms in patients with major depressive disorder in a meta-analysis of randomized controlled trials.














